Clinical Trial Update: HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hepatic arterial infusion chemotherapy plus systemic chemotherapy with lenvatinib and toripalimab in advanced intrahepatic cholangioc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• LENVIMA (lenvatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Intrahepatic Cholangiocarcinoma (Icc) | Phase 2 | Status: COMPLETED